Trials / Recruiting
RecruitingNCT07193485
Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 65 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective
Detailed description
forty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I or group II. the group enroled 20 seniors. both groups wil take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Buteyko breathing | twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks. |
| OTHER | usual care | twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. |
Timeline
- Start date
- 2025-05-12
- Primary completion
- 2025-10-10
- Completion
- 2025-10-10
- First posted
- 2025-09-25
- Last updated
- 2025-09-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07193485. Inclusion in this directory is not an endorsement.